Stress Cardiomyopathy in COVID-19 Disease.

Autor:	Pasqualetto MC; ULSS 3 Serenissima (COVID-19 Hospital), Dolo, Italy., Secco E; ULSS 3 Serenissima (COVID-19 Hospital), Dolo, Italy., Nizzetto M; ULSS 3 Serenissima (COVID-19 Hospital), Dolo, Italy., Scevola M; ULSS 3 Serenissima (COVID-19 Hospital), Dolo, Italy., Altafini L; ULSS 3 Serenissima (COVID-19 Hospital), Dolo, Italy., Cester A; ULSS 3 Serenissima (COVID-19 Hospital), Dolo, Italy., Rigo F; ULSS 3 Serenissima (COVID-19 Hospital), Dolo, Italy.
Jazyk:	angličtina
Zdroj:	European journal of case reports in internal medicine [Eur J Case Rep Intern Med] 2020 May 15; Vol. 7 (6), pp. 001718. Date of Electronic Publication: 2020 May 15 (Print Publication: 2020).
DOI:	10.12890/2020_001718
Abstrakt:	Patients affected by COVID-19 pneumonia may develop stress cardiomyopathy, also known as Takotsubo syndrome (TTS), at different stages during the disease and with different degrees of left ventricular dysfunction. We describe three cases of TTS in COVID-19-positive patients with different clinical presentations and outcomes. One of them died, while in the other two coronary angiography confirmed the diagnosis but was postponed until after pneumonia resolution because of the risk of virus spread. Learning Points: An association between COVID-19 and cardiac involvement is highlighted.The incidence of Takotsubo syndrome has increased during this pandemic, possibly because it is caused by acute stress. Competing Interests: Conflicts of Interests: The Authors declare that there are no competing interests. (© EFIM 2020.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu